Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek

NCT04886232 is registered in ClinicalTrials.gov with Merz North America, Inc. as lead sponsor.

NCT NCT04886232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04886232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek
Lead sponsor
Merz North America, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2021
Completion date
May 16, 2023
Enrollment
202 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cheek volume augmentation